nach oben

Erschienen in:

27.02.2020 | Review

Efficacy and Safety of Endoscopic Sleeve Gastroplasty at Mid Term in the Management of Overweight and Obese Patients: a Systematic Review and Meta-Analysis

verfasst von: Antonio Afonso de Miranda Neto, Diogo Turiani Hourneaux de Moura, Igor Braga Ribeiro, Ahmad Khan, Shailendra Singh, Alberto Machado da Ponte Neto, Antonio Coutinho Madruga Neto, Epifanio Silvino do Monte Junior, Francisco Tustumi, Wanderley Marques Bernardo, Eduardo Guimarães Hourneaux de Moura

Erschienen in: Obesity Surgery | Ausgabe 5/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Endoscopic sleeve gastroplasty (ESG) has emerged as a promising technique in endoscopic bariatric and metabolic therapies (EBMTs). We aimed to perform a systematic review and meta-analysis to provide an update on its efficacy and safety.

Methods

This is a systematic review and meta-analysis was performed following the PRISMA guidelines. MEDLINE, Cochrane, EMBASE, and LILACS were searched to identify the studies related to ESG.

Results

Eleven studies with a total of 2170 patients were included. The average BMI pre-ESG was 35.78 kg/m². Pooled mean %TWL observed at 6, 12, and 18 months was 15.3%, 16.1%, and 16.8% respectively. Pooled mean %EWL at 6, 12, and 18 months was 55.8%, 60%, and 73% respectively. No procedure-related mortality was reported.

Conclusion

ESG is a safe and effective procedure for primary obesity therapy with promising short- and mid-term results.

(WHO) WHO. Obesity and overweight fact sheet [Internet]. 2018. Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight

GBD 2015 Obesity Collaborators, Afshin A, Forouzanfar MH, Reitsma MB, Sur P, Estep K, et al. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med [Internet]. 2017;377:13–27. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28604169

(ASMBS) AS for B and MS. Who is candidate for bariatric surgery? [Internet]. Available from: https://asmbs.org/patients/who-is-a-candidate-for-bariatric-surgery

Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes — 3-year outcomes. N Engl J Med. 2014;370:2002–13. https://doi.org/10.1056/NEJMoa1401329.CrossRefPubMedPubMedCentral

Kashyap SR, Bhatt DL, Schauer PR. STAMPEDE Investigators. Bariatric surgery vs. advanced practice medical management in the treatment of type 2 diabetes mellitus: rationale and design of the Surgical Therapy And Medications Potentially Eradicate Diabetes Efficiently trial (STAMPEDE). Diabetes Obes Metab. 2010;12:452–4. http://www.ncbi.nlm.nih.gov/pubmed/20415694 CrossRefPubMed

Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes - 5-year outcomes. N Engl J Med. 2017;376:641–51. https://doi.org/10.1056/NEJMoa1600869.CrossRefPubMedPubMedCentral

Longitudinal Assessment of Bariatric Surgery (LABS) Consortium, Flum DR, Belle SH, et al. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med. 2009;361:445–54. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19641201 CrossRef

Baptista A, Hourneaux De Moura DT, Jirapinyo P, et al. Efficacy of the cardiac septal occluder in the treatment of post-bariatric surgery leaks and fistulas. Gastrointest Endosc. 2019;89:671–679.e1. Available from: https://linkinghub.elsevier.com/retrieve/pii/S001651071833342X CrossRefPubMed

Ribeiro IB, Gestic MA, Utrini MP, et al. Drain amylase levels may indicate gastrojejunostomy leaks after roux-en-Y gastric bypass. Arq Gastroenterol. 2018;55:66–72. http://www.ncbi.nlm.nih.gov/pubmed/29561980 CrossRefPubMed

10.

de Moura DTH, Ribeiro IB, Funari MP, et al. Novel use of a cardiac septal occluder to treat a chronic recalcitrant bariatric fistula after Roux-en-Y gastric bypass. Endoscopy. 2019;28:3359–65. http://www.ncbi.nlm.nih.gov/pubmed/30791049

11.

Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2011. Obes Surg. 2013;23:427–36. http://www.ncbi.nlm.nih.gov/pubmed/23338049 CrossRefPubMed

12.

Sullivan S, Edmundowicz SA, Thompson CC. Endoscopic bariatric and metabolic therapies: new and emerging technologies. Gastroenterology. 2017;152:1791–801. http://www.ncbi.nlm.nih.gov/pubmed/28192103 CrossRefPubMed

13.

Madruga Neto AC, Bernardo WM, de Moura DT, et al. The effectiveness of endoscopic gastroplasty for obesity treatment according to fda thresholds: systematic review and meta-analysis based on randomized controlled trials. Gastrointest Endosc. 2018;87:AB601. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0016510718325690 CrossRef

14.

de Moura EGH, Ribeiro IB, Frazão MSV, et al. EUS-guided intragastric injection of botulinum toxin a in the preoperative treatment of super-obese patients: a randomized clinical trial. Obes Surg. 2019;29:32–9. https://doi.org/10.1007/s11695-018-3470-y.CrossRefPubMed

15.

Ribeiro IB, de Moura DTH, de Moura EGH. Response to Letter to the Editor Re: “EUS-guided intragastric injection of botulinum toxin a in the preoperative treatment of super-obese patients: a randomized clinical trial”. Obes Surg. 2019;29:1016–7. https://doi.org/10.1007/s11695-018-03665-8.CrossRefPubMed

16.

Abu Dayyeh BK, Rajan E, Gostout CJ. Endoscopic sleeve gastroplasty: a potential endoscopic alternative to surgical sleeve gastrectomy for treatment of obesity. Gastrointest Endosc. 2013;78:530–5. http://www.ncbi.nlm.nih.gov/pubmed/23711556 CrossRefPubMed

17.

Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.CrossRefPubMedPubMedCentral

18.

Cotton PB, Eisen GM, Aabakken L, et al. A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc. 2010;71:446–54. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0016510709026133 CrossRefPubMed

19.

ASGE, Bariatric Endoscopy Task Force, ASGE Technology Committee, et al. ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies. Gastrointest Endosc. 2015;82:425–38.e5. http://www.ncbi.nlm.nih.gov/pubmed/26232362 CrossRef

20.

ASGE/ASMBS Task Force on Endoscopic Bariatric Therapy. A pathway to endoscopic bariatric therapies. Surg Obes Relat Dis. 7:672–82. http://www.ncbi.nlm.nih.gov/pubmed/22082971

21.

de Moura DTH, de Moura EGH, Thompson CC. Endoscopic sleeve gastroplasty: from whence we came and where we are going. World J Gastrointest Endosc. 2019;11:322–8. http://www.ncbi.nlm.nih.gov/pubmed/31205593 CrossRefPubMedPubMedCentral

22.

Moola S, Munn Z, Tufanaru C, Aromataris E, Sears K, Sfetc R, et al. Chapter 7: Systematic reviews of etiology and risk [Internet]. E A, Z M, editors. Joanna Briggs Inst. Rev. Man. 2017. Available from: https://reviewersmanual.joannabriggs.org/

23.

GRADE Working Group. GRADEpro guideline development tool [software]. McMaster Univ. 2015.

24.

Brethauer SA, Kim J, el Chaar M, et al. Standardized outcomes reporting in metabolic and bariatric surgery. Surg Obes Relat Dis. 2015;11:489–506. https://doi.org/10.1016/j.soard.2015.02.003.CrossRefPubMed

25.

Abu Dayyeh BK, Acosta A, Camilleri M, et al. Endoscopic sleeve gastroplasty alters gastric physiology and induces loss of body weight in obese individuals. Clin Gastroenterol Hepatol. 2017;15:37–43.e1. http://www.ncbi.nlm.nih.gov/pubmed/26748219 CrossRefPubMed

26.

Lopez-Nava G, Galvão MP, Bautista-Castaño I, et al. Endoscopic sleeve gastroplasty for obesity treatment: two years of experience. Arq Bras Cir Dig. 2017;30:18–20. http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-67202017000100018&lng=en&tlng=en CrossRefPubMedPubMedCentral

27.

Neto MG, Moon RC, de Quadros LG, et al. Safety and short-term effectiveness of endoscopic sleeve gastroplasty using overstitch: preliminary report from a multicenter study. Surg Endosc. 2019; https://doi.org/10.1007/s00464-019-07212-z.

28.

Saumoy M, Schneider Y, Zhou XK, et al. A single-operator learning curve analysis for the endoscopic sleeve gastroplasty. Gastrointest Endosc. 2018;87:442–7. http://www.ncbi.nlm.nih.gov/pubmed/28843586 CrossRefPubMed

29.

Kumar N, Abu Dayyeh BK, Lopez-Nava Breviere G, et al. Endoscopic sutured gastroplasty: procedure evolution from first-in-man cases through current technique. Surg Endosc. 2018;32:2159–64. http://www.ncbi.nlm.nih.gov/pubmed/29075966 CrossRefPubMed

30.

Sartoretto A, Sui Z, Hill C, et al. Endoscopic sleeve gastroplasty (ESG) is a reproducible and effective endoscopic bariatric therapy suitable for widespread clinical adoption: a large, international multicenter study. Obes Surg. 2018;28:1812–21. http://www.ncbi.nlm.nih.gov/pubmed/29450845 CrossRefPubMed

31.

Graus Morales J, Crespo Pérez L, Marques A, et al. Modified endoscopic gastroplasty for the treatment of obesity. Surg Endosc. 2018;32:3936–42. https://doi.org/10.1007/s00464-018-6133-0.CrossRefPubMed

32.

Alqahtani A, Al-Darwish A, Mahmoud AE, et al. Short-term outcomes of endoscopic sleeve gastroplasty in 1000 consecutive patients. Gastrointest Endosc. 2019;89:1132–8. http://www.ncbi.nlm.nih.gov/pubmed/30578757 CrossRefPubMed

33.

Barrichello S, Hourneaux de Moura DT, Hourneaux de Moura EG, et al. Endoscopic sleeve gastroplasty in the management of overweight and obesity: an international multicenter study. Gastrointest Endosc. 2019;90:770–80. http://www.ncbi.nlm.nih.gov/pubmed/31228432 CrossRefPubMed

34.

Espinet Coll E, Vila Lolo C, Díaz Galán P, et al. Bariatric and metabolic endoscopy in the handling of fatty liver disease. A new emerging approach? Rev Esp Enferm Dig NLM. 2019;111:283–93. https://online.reed.es/fichaArticulo.aspx?iarf=685760745233-414272195163

35.

Bhandari M, Jain S, Mathur W, Kosta S, Neto MG, Brunaldi VO, et al. Endoscopic sleeve gastroplasty is an effective and safe minimally invasive approach for treatment of obesity: first Indian experience. Dig Endosc. Wiley; 2019;den.13508. https://doi.org/10.1111/den.13508 CrossRefPubMed

36.

Glaysher MA, Moekotte AL, Kelly J. Endoscopic sleeve gastroplasty: a modified technique with greater curvature compression sutures. Endosc Int open. 2019;07:E1303–9.CrossRef

37.

Cheskin LJ, Hill C, Adam A, Fayad L, Dunlap M, Badurdeen D, et al. Endoscopic sleeve gastroplasty versus high-intensity diet and lifestyle therapy: a case-matched study. Gastrointest Endosc. Elsevier BV; 2019 https://linkinghub.elsevier.com/retrieve/pii/S0016510719322965

38.

Sharaiha RZ, Kedia P, Kumta N, et al. Initial experience with endoscopic sleeve gastroplasty: technical success and reproducibility in the bariatric population. Endoscopy. 2015;47:164–6. http://www.ncbi.nlm.nih.gov/pubmed/25380510 PubMed

39.

Lopez-Nava G, Sharaiha RZ, Vargas EJ, et al. Endoscopic sleeve gastroplasty for obesity: a multicenter study of 248 patients with 24 months follow-up. Obes Surg. 2017;27:2649–55. http://www.ncbi.nlm.nih.gov/pubmed/28451929 CrossRefPubMed

40.

López-Nava-Breviere G, Bautista-Castaño I, Fernández-Corbelle JP, et al. Endoscopic sleeve gastroplasty (the Apollo method): a new approach to obesity management. Rev Esp Enferm Dig. 2016;108:201–6.CrossRefPubMed

41.

Lopez-Nava G, Galvao M, Bautista-Castaño I, et al. Endoscopic sleeve gastroplasty with 1-year follow-up: factors predictive of success. Endosc Int open. 2016;4:E222–7. http://www.ncbi.nlm.nih.gov/pubmed/26878054 CrossRefPubMedPubMedCentral

42.

Lopez-Nava G, Galvão MP, Bautista-Castaño I, et al. Endoscopic sleeve gastroplasty: how I do it? Obes Surg. 2015;25:1534–8. http://www.ncbi.nlm.nih.gov/pubmed/26003549 CrossRefPubMed

43.

Lopez-Nava G, Galvão MP, da Bautista-Castaño I, et al. Endoscopic sleeve gastroplasty for the treatment of obesity. Endoscopy. 2015;47:449–52. https://doi.org/10.1055/s-0034-1390766.CrossRefPubMed

44.

Fayad L, Adam A, Schweitzer M, et al. Endoscopic sleeve gastroplasty versus laparoscopic sleeve gastrectomy: a case-matched study. Gastrointest Endosc. 2019;89:782–8. http://www.ncbi.nlm.nih.gov/pubmed/30148991 CrossRefPubMed

45.

Novikov AA, Afaneh C, Saumoy M, et al. Endoscopic sleeve gastroplasty, laparoscopic sleeve gastrectomy, and laparoscopic band for weight loss: how do they compare? J Gastrointest Surg. 2018;22:267–73. http://www.ncbi.nlm.nih.gov/pubmed/29110192 CrossRefPubMed

46.

Sharaiha RZ, Kumta NA, Saumoy M, et al. Endoscopic sleeve gastroplasty significantly reduces body mass index and metabolic complications in obese patients. Clin Gastroenterol Hepatol. 2017;15:504–10. http://www.ncbi.nlm.nih.gov/pubmed/28017845 CrossRefPubMed

47.

Fayad L, Cheskin LJ, Adam A, et al. Endoscopic sleeve gastroplasty versus intragastric balloon insertion: efficacy, durability, and safety. Endoscopy. 2019;51:532–9. https://doi.org/10.1055/a-0852-3441.CrossRefPubMed

48.

Moura D, Oliveira J, De Moura EGH, et al. Effectiveness of intragastric balloon for obesity: a systematic review and meta-analysis based on randomized control trials. Surg Obes Relat dis. 2016;12:420–9. https://doi.org/10.1016/j.soard.2015.10.077.CrossRefPubMed

49.

Madruga-Neto AC, Bernardo WM, de Moura DTH, et al. The effectiveness of endoscopic gastroplasty for obesity treatment according to FDA thresholds: systematic review and meta-analysis based on randomized controlled trials. Obes Surg. 2018;28:2932–40. http://www.ncbi.nlm.nih.gov/pubmed/29909512 CrossRefPubMed

50.

Singh S, Hourneaux de Moura DT, Khan A, et al. Safety and efficacy of endoscopic sleeve gastroplasty worldwide for treatment of obesity: a systematic review and meta-analysis. Surg Obes Relat Dis. 2019; https://linkinghub.elsevier.com/retrieve/pii/S155072891931113X

51.

McCarty TR, Jirapinyo P, Thompson CC. Effect of sleeve gastrectomy on ghrelin, GLP-1, PYY, and GIP gut hormones: a systematic review and meta-analysis. Ann Surg Ovid Technol. 2019;1 http://insights.ovid.com/crossref?an=00000658-900000000-94872

Titel: Efficacy and Safety of Endoscopic Sleeve Gastroplasty at Mid Term in the Management of Overweight and Obese Patients: a Systematic Review and Meta-Analysis
verfasst von: Antonio Afonso de Miranda Neto
Diogo Turiani Hourneaux de Moura
Igor Braga Ribeiro
Ahmad Khan
Shailendra Singh
Alberto Machado da Ponte Neto
Antonio Coutinho Madruga Neto
Epifanio Silvino do Monte Junior
Francisco Tustumi
Wanderley Marques Bernardo
Eduardo Guimarães Hourneaux de Moura
Publikationsdatum: 27.02.2020
Verlag: Springer US
Erschienen in: Obesity Surgery / Ausgabe 5/2020
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI: https://doi.org/10.1007/s11695-020-04449-9

Neu im Fachgebiet Chirurgie

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Deutlich weniger Infektionen: Wundprotektoren schützen!

08.05.2024 Postoperative Wundinfektion Nachrichten

Der Einsatz von Wundprotektoren bei offenen Eingriffen am unteren Gastrointestinaltrakt schützt vor Infektionen im Op.-Gebiet – und dient darüber hinaus der besseren Sicht. Das bestätigt mit großer Robustheit eine randomisierte Studie im Fachblatt JAMA Surgery.

Chirurginnen und Chirurgen sind stark suizidgefährdet

07.05.2024 Suizid Nachrichten

Der belastende Arbeitsalltag wirkt sich negativ auf die psychische Gesundheit der Angehörigen ärztlicher Berufsgruppen aus. Chirurginnen und Chirurgen bilden da keine Ausnahme, im Gegenteil.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare

CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare

CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske

Dr. med. Benjamin Meyknecht

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare

CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

Efficacy and Safety of Endoscopic Sleeve Gastroplasty at Mid Term in the Management of Overweight and Obese Patients: a Systematic Review and Meta-Analysis